Search Results 2461-2470 of 18329 for rheumatoid arthritis

  1. Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations - Mayo Clinic

    ... factor receptor (EGFR) mutations. Erlotinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies ...

  2. Arthroscopy - Doctors & Departments - Mayo Clinic

    Related. Arthritis · Baker cyst · Hip dysplasia · Hip labral tear · Knee pain · Patellofemoral pain syndrome · Swollen knee · Thumb arthritis · Torn meniscus ...

  3. Orthopedics/Sports - 2013 Archives - Mayo Clinic News Network

    Arthritis now afflicts nearly 1 in 4 American adults, the Centers for Disease Control[...] Water Sports and Concussions (pkg). Dana Sparks. October 8, 2013.

  4. Publications - Folakemi T. Odedina, Ph.D. - Mayo Clinic

    Prostate Cancer Screening and Strategies, Florida Behavioral Risk Factor Surveillance System, 2012-2020. Prev Chronic Dis. 2023 Nov 22; 20:E108 View PubMed ...

  5. In case you missed it: This week's Top 5 stories on social media - Mayo Clinic News Network

    PCOS is also a significant risk factor for endometrial cancer.⁠. Pregnancy-related heart failure is under-detected; AI-enabled stethoscope helped doctors ...

  6. RESET-Myositis: Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy - Mayo Clinic

    ... Rheumatology classification criteria * Diagnosis of DM, ASyS, IMNM based on the presence of serum myositis-specific antibodies * Evidence of active disease ...

  7. Skeletal Development and Regeneration Research Laboratory

    Dr. Westendorf receives grant funding from the U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) within the U.S. National ...

  8. Publications - Mark T. T. Keegan, M.D. - Mayo Clinic

    2006 Jul; 34(7):1892-7. View PubMed; Fernandez-Perez ER, Keegan MT, Brown DR, Hubmayr RD, Gajic O. Intraoperative tidal volume as a risk factor for respiratory ...

  9. Phase I Clinical Trial of Autologous Adipose Derived Mesenchymal Stem Cells in the Treatment of Paralysis due to Traumatic Spinal Cord Injury

    Taking anti-rheumatic disease medication (including methotrexate or other antimetabolites) within 3 months prior to study enrollment. Ongoing infectious ...

  10. Publications - Xinjie Xu, Ph.D. - Mayo Clinic

    Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with "7+3". Blood Cancer J 2022 Apr 7; 12 (4):55 Epub 2022 ...